手术衣市场:现状分析与预测(2022-2030年)
市场调查报告书
商品编码
1290906

手术衣市场:现状分析与预测(2022-2030年)

Surgical Gowns Market: Current Analysis and Forecast (2022-2030)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 140 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

由于医疗旅游业的全球扩张,手术服市场预计将稳定增长10%左右。例如,根据医疗旅游协会的数据,全球每年有近 1400 万人前往不同国家寻求医疗服务。这项活动价值在 50,000 美元到 70,000 美元之间。由于这些事实以及外科手术国际标准的不断遵守,预计手术服市场在预测期内也将增长。

为了更好地了解手术衣行业的市场采用情况,我们根据其在北美(美国、加拿大、北美其他地区)、欧洲(德国、英国、法国、西班牙)等国家/地区的全球分布对市场进行了分析。 、意大利、欧洲其他地区)、亚太地区(中国、日本、印度、亚太地区其他地区)、世界其他地区。由于慢性病患病率不断上升,预计北美在预测期内将以復合年增长率大幅增长疾病如癌症和糖尿病,加上人口老龄化,正在推动对手术服的需求。包括微创手术在内的手术的增加也促进了市场的增长。手术服的采用,特别是可重复使用的选择,具有成本效益和环境可持续。

目录

第1章 市场简介

  • 市场定义
  • 主要目的
  • 相关利益者
  • 限制事项

第2章 调查手法或前提

  • 调查流程
  • 调查手法
  • 受访者简介

第3章 市场摘要

第4章 摘要整理

第5章 COVID-19对手术衣市场带来的影响

第6章 手术衣的市场收益,2020-2030年

第7章 市场洞察:各产品

  • 抛弃式
  • 可重复使用

第8章 市场洞察:各流通管道

  • 线上销售
  • 零售药局
  • 直销

第9章 市场洞察:各最终用途

  • 医院
  • 门诊病人手术中心
  • 诊断中心
  • 诊所
  • 其他

第10章 市场洞察:各最终用途

  • 製药公司及生物医药品公司
  • 临床调查机构
  • 医疗保健提供者

第11章 市场洞察:各地区

  • 北美
    • 美国
    • 加拿大
    • 其他北美地区
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 全球其他地区

第12章 手术衣市场动态

  • 推动市场要素
  • 市场课题
  • 影响分析

第13章 手术衣市场机会

第14章 手术衣市场趋势

第15章 需求面和供给面的分析

  • 需求面分析
  • 供给面分析

第16章 价值链分析

第17章 价格分析

第18章 策略性洞察能力

第19章 竞争模式

  • 竞争情形
    • 波特的五力分析

第20章 企业简介

  • Cardinal Health
  • 3M
  • Molnlycke Health Care AB
  • Owens & Mino
  • Thermo Fisher Scientific Inc.
  • STERIS
  • PAUL HARTMANN AG
  • Johnson & Johnson Private Limited
  • Medica Europe B.V.
  • Medline Industries, Inc.

第21章 免责声明

简介目录
Product Code: UMHE2118021

Patients receiving care or being inspected at a clinic or hospital, as well as doctors performing procedures, wear surgical gowns, which are short, collarless gowns tied at the back. The surgical gown market is growing on account of the growing number of surgeries and increasing incidences of healthcare-associated infections (HAIs) which are directly associated with the lack of precaution and sanitation. For instance, every year 1.7 million people get an infection during a hospital stay. Also, almost 98,987 people in the U.S. die annually from HAIs. Furthermore, some other factors also boost the growth of the market such as new technological advancement in the healthcare sector and an increase in healthcare expenditure.

The surgical gowns market is expected to grow at a steady rate of around 10% owing to the growing medical tourism industry across the globe is also driving the market globally. For instance, according to the Medical Tourism Association, nearly 14 million people around the globe travel to different countries in search of medical care per year. It is an activity worth between 50 and 70 thousand million dollars. Owing to these facts and growing compliance towards an international standard for surgical procedures, the surgical gowns market is also expected to grow during the forecast period.

Based on product, the market is segmented into disposable and reusable. The disposable category is to witness higher adoption during the forecast period as they are cost-effective and are recommended over reusable gowns in terms of safety and quality. Disposable gowns are made from hypoallergenic and dermatological-certified materials and serve to limit the danger of infection and cross-contamination among patients. Also, the growth of the market is accelerated by some factors such as the increasing number of surgical procedures due to sports injuries, accidents, and heart surgeries owing to a high prevalence of chronic diseases where surgery is being suggested. For instance, according to the OECD stats, in the United Kingdom, the total number of surgical procedures performed was 4,82,938 in 2017 and it increased to 5,40,947 in 2019.

On the basis of distribution channel, the market is categorized into online sales, retail pharmacies, and direct sales. Among these, retail pharmacies held a significant share of the market in 2021. This is mainly due to being easily accessible to patients and healthcare providers, convenient options for patients, more affordable for patients, compliance with regulations, and retail pharmacies can create awareness among their customers about the importance of surgical gowns which will boost the growth of the market.

Based on end-user, the surgical gowns market has been classified into hospitals, ambulatory surgical centers, diagnostic centers, clinics, and others. The military and defense category is to witness higher adoption of surgical gowns during the forecast period. This is mainly due to the majority of surgical gowns are utilized in hospitals, the rising prevalence of chronic diseases, improving healthcare infrastructure, and the expanding number of hospitals. The spreading of viral infections and the constant rise in surgical procedures chosen by patients worldwide to treat chronic diseases.

For a better understanding of the market adoption of the surgical gowns industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period owing to the increasing prevalence of chronic diseases such as cancer and diabetes, coupled with an aging population, is driving the demand for surgical gowns. The rise in surgeries, including minimally invasive procedures, is also contributing to market growth. In addition, the focus on infection control measures in healthcare facilities is driving the adoption of surgical gowns, particularly reusable options, which are cost-effective and environmentally sustainable. The implementation of stringent regulatory guidelines is also expected to contribute to market growth in the region.

Some of the major players operating in the market include: Cardinal Health; 3M; Molnlycke Health Care AB; Owens & Mino; Thermo Fisher Scientific Inc.; STERIS; PAUL HARTMANN AG; Johnson & Johnson Private Limited; Medica Europe B.V.; Medline Industries, Inc.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Surgical Gowns Market
  • 2.2. Research Methodology of the Surgical Gowns Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE SURGICAL GOWNS MARKET

6 SURGICAL GOWNS MARKET REVENUE, 2020-2030F

7 MARKET INSIGHTS BY PRODUCT

  • 7.1. Disposable
  • 7.2. Reusable

8 MARKET INSIGHTS BY DISTRIBUTION CHANNEL

  • 8.1. Online Sales
  • 8.2. Retail Pharmacies
  • 8.3. Direct Sales

9 MARKET INSIGHTS BY END-USER

  • 9.1. Hospitals
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Diagnostic Centers
  • 9.4. Clinics
  • 9.5. Others

10 MARKET INSIGHTS BY END-USERS

  • 10.1. Pharmaceutical & Biopharmaceutical Companies
  • 10.2. Clinical Research Organization
  • 10.3. Healthcare Providers

11 MARKET INSIGHTS BY REGION

  • 11.1. North America
    • 11.1.1. U.S.
    • 11.1.2. Canada
    • 11.1.3. Rest of North America
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. U.K.
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Rest of Asia-Pacific
  • 11.4. Rest of World

12 SURGICAL GOWNS MARKET DYNAMICS

  • 12.1. Market Drivers
  • 12.2. Market Challenges
  • 12.3. Impact Analysis

13 SURGICAL GOWNS MARKET OPPORTUNITIES

14 SURGICAL GOWNS MARKET TRENDS

15 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 15.1. Demand Side Analysis
  • 15.2. Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 PRICING ANALYSIS

18 STRATEGIC INSIGHTS

19 COMPETITIVE SCENARIO

  • 19.1. Competitive Landscape
    • 19.1.1. Porters Fiver Forces Analysis

20 COMPANY PROFILED

  • 20.1. Cardinal Health
  • 20.2. 3M
  • 20.3. Molnlycke Health Care AB
  • 20.4. Owens & Mino
  • 20.5. Thermo Fisher Scientific Inc.
  • 20.6. STERIS
  • 20.7. PAUL HARTMANN AG
  • 20.8. Johnson & Johnson Private Limited
  • 20.9. Medica Europe B.V.
  • 20.10. Medline Industries, Inc.

21 DISCLAIMER